Priya Chockalingam

Priya Chockalingam

Company: Beam Therapeutics

Job title: Vice President, Head of Clinical Bioanalytics & Translational Sciences


Priya has a PhD in biochemistry. She is the Head of Clinical Bioanalytics & Translational Sciences at Beam Therapeutics that has clinical programs in hematology, oncology, and rare genetic diseases that leverage base editing technologies, auto/allo cell therapies and novel delivery modalities like LNP. Prior to Beam, she worked for 20+ years on Translational Medicine, Bioanalytics, Biomarkers & Diagnostics at Wyeth, Pfizer, Takeda (L-Shire) and Biogen.


Addressing Key Translational Challenges of Base Editing Technology 1:45 pm

For somatic base editing programs, how can a drug sponsor prove no germline edits have occurred? Detection of on- and off-target genome editing events in the clinical setting Outlining the unique regulatory considerations for clearing an IND with a base editing programRead more

day: Day 2 Track B PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.